Switch View
© BusinessWire
11.09.2025
ISIN: US92532F1003
Vertex Pharmaceuticals Inc
VRTX
LISTED
NASDAQ
Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis
News Preview
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year’s Lasker~DeBakey Clinical Medical Research Award for his role “in the development of a novel, life-saving treatment for cystic fibrosis (CF) — namely, a triple-drug combination therapy, TRIK...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US45784A1043
InnovAge Holding Corp
INNV
LISTED
NASDAQ
InnovAge Named as One of the Nation’s Best Workplaces in Aging Services™ by Fortune® and Great Place to Work®
News Preview
InnovAge named a top 15 Best Workplace in Aging Services by Fortune & Great Place to Work®, honoring its culture of care and dedicated PACE team....
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: KR7328130000
Lunit Inc.
328130
LISTED
KOE
Lunit Awarded Major National Tender in France, Expanding Access to Breast AI in Public Hospitals
News Preview
Framework agreement with UniHA enables access to Lunit's breast AI solutions across 1,500+ French public hospitals, in collaboration with Fujifilm
SEOUL, South Korea, Sept. 11, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that its breast imaging AI solutions have bee...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
11.09.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025
News Preview
Press release – No.13 / 2025...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
11.09.2025
ISIN: CA65347A1021
Nextleaf Solutions Ltd.
OILS
LISTED
CSE
Nextleaf Provides Strategic Update: Canada's First 200-Pack Cannabis Softgels, and Opening of Distribution Facility
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life science company and licensed cannabis processor announces the launch of Canada's first 200-pack cannabis softgels under its house brand Glacial GoldT...
Themefolio
Profiler
Peergroup
© Newsfile
11.09.2025
ISIN: CA88410L1022
Thiogenesis Therapeutics, Corp.
TTI
LISTED
TSX
Thiogenesis Reports on 2025 Annual General Meeting of Shareholders and Provides Corporate Update
News Preview
San Diego, California--(Newsfile Corp. - September 11, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biopharmaceutical company developing sulfur-based therapeutics for serious pediatric diseases, today announced the results of its Annual General Meeting of Shareholders ("AGM")...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. Class Action: The Gross Law Firm Reminds Semler Scientific, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2025 - SMLR
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders who purchased shares of SMLR during the class period listed are encoura...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Investors who lost money on LifeMD, Inc.(LFMD) should contact The Gross Law Firm about pending Class Action - LFMD
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchased shares of LFMD during the class period listed are encouraged to cont...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
October 21, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NUTX
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who purchased shares of NUTX during the class period listed are encouraged to...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
NEOG LAWSUIT ALERT: The Gross Law Firm Notifies Neogen Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Neogen Corporation (NASDAQ: NEOG).
Shareholders who purchased shares of NEOG during the class period listed are encouraged t...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
REPL LAWSUIT ALERT: The Gross Law Firm Notifies Replimune Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL).
Shareholders who purchased shares of REPL during the class period listed are encourage...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Shareholders that lost money on Alto Neuroscience, Inc.(ANRO) should contact The Gross Law Firm about pending Class Action - ANRO
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO).
Shareholders who purchased shares of ANRO during the class period listed are encourage...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
11.09.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
Altimmune, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 6, 2025 to Discuss Your Rights - ALT
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. (NASDAQ: ALT).
Shareholders who purchased shares of ALT during the class period listed are encouraged to con...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Investors in Unicycive Therapeutics, Inc. Should Contact The Gross Law Firm Before October 14, 2025 to Discuss Your Rights - UNCY
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY).
Shareholders who purchased shares of UNCY during the class period listed are en...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
Capricor Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights - CAPR
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR).
Shareholders who purchased shares of CAPR during the class period listed are enc...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RxSight, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - RXST
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST).
Shareholders who purchased shares of RXST during the class period listed are encouraged to con...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Shareholders that lost money on Biohaven Ltd.(BHVN) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Biohaven Ltd. (NYSE: BHVN).
Shareholders who purchased shares of BHVN during the class period listed are encouraged to conta...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US2666055007
DURECT Corp
DRRX
LISTED
NASDAQ
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
News Preview
The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health's hepatology pipeline
LAVAL, QC, and CUPERTINO, Calif., Sept. 11, 2025 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC) ("Bausch Health"), a global, diver...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US6373722023
National Research Corp
NRC
LISTED
NASDAQ
NRC Health Welcomes South Shore Health to Advance Patient and Employee Experience
News Preview
NRC Health is proud to welcome South Shore Health as its newest partner in healthcare experience excellence. This strategic collaboration reflects South Shore’s commitment to advancing patient and employee experience through innovative, human-centered solutions and a trusted support model.
This press release features multimedia. View the full rel...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Announces Pricing of Secondary Offering of Common Stock
News Preview
LEHI, Utah, and LOUISVILLE, Ky., Sept. 11, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) ("Waystar"), a provider of leading healthcare payments software, today announced the pricing of the previously announced underwritten secondary offering by certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: CA13509T1057
MTL Cannabis Corp.
MTLC
LISTED
CSE
MTL Cannabis Corp. Expands Global Reach with Launch of Branded Products into Australian Medical Market
News Preview
PICKERING, ON, Sept. 11, 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) (OTCQX: MTLNF) ("MTL" or the "Company") is pleased to announce the official launch of its premium branded cannabis products into the rapidly growing Australian medical market....
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Tempus Pixel, an AI-powered cardiac imaging platform. This update allows the generation of T1 and T2 inline maps, further enh...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US69380Q1076
PACS Group, Inc.
PACS
LISTED
NYSE
PACS Group Announces NYSE Listing Extension and Provides Select Preliminary Interim Operating Metrics
News Preview
PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), on September 10, 2025, announced that on September 9, 2025, the New York Stock Exchange (“NYSE”) Listing Operations Committee agreed to provide the Company with an additional trading period through November 19, 2025, subject to its ongoing review of the Company. The additional trading period...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it has reached a strategic agreement with LabFlorida/SunDx Labs to provide residents of senior living communities access to Guardant Shield™, the first blood test approved by the U.S. Food and Drug Administration (FDA) as a primary screening option for colore...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US48301N1046
Kairos Pharma Ltd
KAPA
LISTED
XASE
Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer
News Preview
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces that it will host a premier KOL event on Thursday, Sept. 18th at 5 p.m. ET / 2 p.m. PT to discuss diverse perspectives on the Company’s interim efficacy results from a Phase 2 trial of its lead candidate,...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) has recently announced two strategic collaborations across its contract development and manufacturing organization (CDMO), aimed at advancing novel oncology research and development. These collaborations include forming an alliance with the Parker Institute for Cancer Immunotherapy and sup...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US5747951003
Masimo Corporation
MASI
LISTED
NASDAQ
Masimo Announces Expansion of Strategic Partnership with Philips
News Preview
Masimo (NASDAQ: MASI) today announced a multi-year renewal and expansion of its strategic partnership with Royal Philips (NYSE: PHG, AEX: PHIA).
Building on over two decades of collaboration, this significant partnership expansion is designed to accelerate the integration of Masimo’s monitoring technologies, such as industry-leading SET® pulse o...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US04280A1007
Arrowhead Pharmaceuticals Inc
ARWR
LISTED
NASDAQ
Arrowhead Pharmaceuticals Files Complaint for Declaratory Judgment Against Ionis Pharmaceuticals
News Preview
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that yesterday it filed a Complaint for Declaratory Judgment in the United States District Court for the District of Delaware against Ionis Pharmaceuticals, Inc., to declare that Ionis’s United States Patent No. 9,593,333 (“the ’333 patent”) is invalid and not infringed by Arrowhead’s...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US5526411021
MAIA Biotechnology Inc
MAIA
LISTED
XASE
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
News Preview
CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today highlighted positive efficacy data from its Phase 2 clinical trial, THIO-101, evaluating ateganosine (THIO) sequenced with t...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: KYG1281K1067
Silexion Therapeutics Corp
SLXN
LISTED
NASDAQ
Silexion Therapeutics Announces Pricing of $6.0 Million Public Offering
News Preview
Grand Cayman, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced the pricing of a public offering of an aggregate of 1,500,000 of the Company’s ordinary shares (or o...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US45258H1068
Immix Biopharma, Inc.
IMMX
LISTED
NASDAQ
Nancy T. Chang, Proven Biotechnology Leader, Joins Immix Biopharma Board of Directors
News Preview
– Dr. Chang led XOLAIR® from invention through FDA approval and commercialization, exceeding $5 billion in sales so far – ...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Gilead Sciences entscheidet sich für Veeva Vault CRM
News Preview
CRM der nächsten Generation mit umfassenden Funktionen und agentenbasierter KI
PLEASANTON, Calif., 11. September 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) gab heute bekannt, dass sich Gilead Sciences für Veeva Vault CRM entschieden hat.
„Gilead ist ein führender Anbieter von lebensverändernden Medikamenten und hat wichtige wissenschaftlich...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards® Program
News Preview
— Competitive Grant Program to Offer Individual Grants of Up to $100,000 per Project —
— Areas of Interest Expanded to Include Sleep and Circadian Disturbances Associated With Bipolar I Disorder and/or Schizophrenia —
— Application Period to Run From Sept. 15, 2025 Through Dec. 15, 2025 —
DUBLIN, Sept. 11, 2025 /PRNewswire/ -- Alkermes plc (Nasda...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards® Program
News Preview
— Competitive Grant Program to Offer Individual Grants of Up to $100,000 per Project —
— Areas of Interest Expanded to Include Sleep and Circadian Disturbances Associated With Bipolar I Disorder and/or Schizophrenia —
— Application Period to Run From Sept. 15, 2025 Through Dec. 15, 2025 —
DUBLIN, Sept. 11, 2025 /PRNewswire/ -- Alkermes plc (Nasda...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US04746L1044
Athira Pharma, Inc
ATHA
LISTED
NASDAQ
Athira Pharma Announces Reverse Stock Split
News Preview
BOTHELL, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (“Athira” or “Company”) (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that it will effect a 10-for-1 reverse stock split of Athira’s issued and authorized...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US31447E1055
Femasys Inc
FEMY
LISTED
NASDAQ
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®
News Preview
-- Following the Setup Kit, the Insemination Kit completes the sperm preparation portion of FemSperm enabling gynecology call point activation to drive revenue growth -- -- Following the Setup Kit, the Insemination Kit completes the sperm preparation portion of FemSperm enabling gynecology call point activation to drive revenue growth --...
Themefolio
Profiler
Peergroup
© Newsfile
11.09.2025
ISIN: CA90429T1003
Unbuzzd Wellness Inc.
UNBZ
LISTED
CSE
Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2025) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM - the scientifically-proven and game-changing beverage that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms - today announced that the Company will host an Invest...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Quarter Financial Results
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today provided an operational update and released financial results for the fiscal quarter ended July 31, 2025.
“This quarter marked a defining moment in the history of KalVista with the FDA approval of EKTERLY—the first and only oral on-demand treatment for HAE,” stated Ben Palleiko, CEO of KalVist...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 3 STRIDE-13 trial evaluating CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) at the 6th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Conference on Vaccines, taking place in Lisbon, Portugal. T...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US53635D2027
Liquidia Corp
LQDA
LISTED
NASDAQ
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium
News Preview
MORRISVILLE, N.C., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the company will present four posters at the Pulmonary Hypertension Professional Association (PHPN) Symposium taking place Septe...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US31573L1052
FibroBiologics Inc.
FBLG
LISTED
NASDAQ
FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment
News Preview
Pilot studies underway to advance IND-enabling preclinical development Pilot studies underway to advance IND-enabling preclinical development...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US5288723027
Lexicon Pharmaceuticals Inc
LXRX
LISTED
NASDAQ
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings
News Preview
Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic pain (DPNP)...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04 NET ASSET VALUE The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 10 September 2025 was 359.43p (cum income). ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US15117F3029
Cellectar Biosciences, Inc.
CLRB
LISTED
NASDAQ
Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225
News Preview
Supports Clinical Development of CLR 121225, Actinium-Labeled Compound for the Treatment of Solid Tumors Supports Clinical Development of CLR 121225, Actinium-Labeled Compound for the Treatment of Solid Tumors...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US00091E1091
Absci Corp
ABSI
LISTED
NASDAQ
Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD
News Preview
Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costs Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costs...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US09075X1081
Biodesix Inc
BDSX
LISTED
NASDAQ
Biodesix Announces One-for-Twenty Reverse Stock Split
News Preview
LOUISVILLE, Colo., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX) (“Biodesix” or the “Company”), a leader in personalized diagnostics, today announced a one-for-twenty reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.001, which will become effective at 12:01 a.m. Eastern Time on Monday,...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: CA45074T1021
Ianthus Capital Holdings Inc.
IAN
LISTED
CSE
iAnthus Expands Florida Footprint with GrowHealthy Dispensary Opening in Tamarac
News Preview
iAnthus Continues Expansion in Florida with GrowHealthy Dispensary of Tamarac...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant and support its further adoption. Substantial investment into research to expand access and indications have led to these important results designed to...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US2214133058
Cosmos Health Inc
COSM
LISTED
NASDAQ
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
News Preview
Cosmos Health signs distribution deal with Scientific Pharmacy to launch Sky Premium Life in Oman, including an initial order of 42,000 supplement units....
Themefolio
Profiler
Peergroup
© Newsfile
11.09.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness QSR Announces Their Multi Unit Franchisee Has Signed a New Location in South Surrey, British Columbia
News Preview
Toronto, Ontario--(Newsfile Corp. - September 11, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce that Heal Wellness has secured a real-estate location in South Surrey's Grandview Central. The franchisee is an experienced m...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US5787841007
Maze Therapeutics Inc
MAZE
LISTED
NASDAQ
Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement
News Preview
Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US5787841007
Maze Therapeutics Inc
MAZE
LISTED
NASDAQ
Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (PKU) and Chronic Kidney Disease (CKD)
News Preview
Phase 1 data in healthy volunteers exceed expectations and support best-in-class potential, enabling Phase 2 advancement for both intended indications of PKU and CKD...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US03770N1019
Apogee Therapeutics Inc
APGE
LISTED
NASDAQ
Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress
News Preview
SAN FRANCISCO and BOSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, today announced data from the Phase 2 APEX trial of APG777 for m...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: GB00BMVP7Y09
Royalty Pharma PLC
RPRX
LISTED
NASDAQ
Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value Creation
News Preview
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) will host an Investor Day in New York City today. Senior executives will provide an update on the company’s plans to drive shareholder value creation through its unique business model and capabilities in the large and growing market for funding biopharma innovation wit...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: KYG1281K1067
Silexion Therapeutics Corp
SLXN
LISTED
NASDAQ
Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204’s Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration
News Preview
New Positive Preclinical Data Shows Succesful Drug Distribution to Liver, Peritoneum, and Lung with Measurable Reductions in Tumor Burden at Clinically Relevant Doses...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting
News Preview
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, will present clinical and preclinical data from its portfolio of next-generation ultra-long acting, scalable, and combinable therapies at the 61st A...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: US74365A3095
Protalix Biotherapeutics Inc
PLX
LISTED
XASE
Protalix BioTherapeutics to Present at Investor Summit Virtual
News Preview
CARMIEL, ISRAEL / ACCESS Newswire / September 11, 2025 / Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced that Eyal Ru...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US8793691069
Teleflex Inc
TFX
LISTED
NYSE
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
News Preview
The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents...
Themefolio
Profiler
Peergroup
© Newsfile
11.09.2025
ISIN: CH1129677105
Medmix AG
MEDX
LISTED
SIX
medmix Announces Strategic Partnership with Gurit for Sustainable Solutions for Industrial Bonding Applications
News Preview
Baar, Switzerland--(Newsfile Corp. - September 11, 2025) - medmix AG Neuhofstrasse 20 CH-6430 Baarcommunications@medmix.com www.medmix.swissMEDIA RELEASEDOWNLOAD MEDIA RELEASEmedmix Announces Strategic Partnership with Gurit for Sustainable Solutions for Industrial Bonding Applications medmix has partnered...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC Pink:MDCE) Subsidiary Infinite Auctions Secures $2.54M Memorabilia Inventory, Reinforcing Growth and Supporting AI Healthcare Mission
News Preview
With high-value assets including a LeBron James 2016 NBA Finals game worn jersey and rare Tom Brady 1/1 card, Infinite Auctions bolsters MDCE's balance sheet to accelerate development of its AI health platform. MESA, ARIZONA / ACCESS Newswire / September 11, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today announced that its subsidiary I...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
